Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Hold” from Brokerages

Teleflex Incorporated (NYSE:TFX) has earned an average rating of “Hold” from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $139.00.

Several brokerages recently weighed in on TFX. Needham & Company LLC upgraded Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price on the stock in a research note on Tuesday, January 27th. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $135.00 price objective on shares of Teleflex in a research report on Wednesday, December 17th. Truist Financial boosted their target price on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Finally, Wells Fargo & Company cut their price target on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 29th.

Teleflex Price Performance

Shares of TFX opened at $115.55 on Monday. The company has a 50 day moving average of $112.23 and a two-hundred day moving average of $118.78. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. Teleflex has a twelve month low of $100.18 and a twelve month high of $180.58. The company has a market cap of $5.11 billion, a price-to-earnings ratio of -15.72, a price-to-earnings-growth ratio of 1.50 and a beta of 0.92.

Institutional Trading of Teleflex

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the period. Banque Cantonale Vaudoise boosted its position in Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. Hantz Financial Services Inc. increased its holdings in Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in Teleflex during the 3rd quarter worth approximately $35,000. Finally, True Wealth Design LLC lifted its stake in Teleflex by 10,333.3% during the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after acquiring an additional 310 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.